Clinical Cooperations

Translational Research at Helmholtz Zentrum München

The objective of translational research is to transfer knowlegde that has been acquired by basic research into practical use and turn it into innovation. Successful project development essentially relies on a value driven cooperation of different disciplines and a close exchange between basic scientists and clinicians.

This interdisciplinary research approach is realized within Translational Research Centers and the following Clinical Cooperations:

Diabetes

Nutrigenomics and Typ 2 Diabetes mellitus (Hauner)

The functional elucidation of genetic risk variants for type 2 diabetes and obesity is opening up new strategies to prevent and treat these diseases. Helmholtz Zentrum München is jointly pursuing this objective in a clinical cooperation group with Technische Universität München and the University Hospital rechts der Isar.

Head: Prof. Dr. Hans Hauner
Tel. +49 8161 71-2000

 

More information about CCG Nutrigenomics and Typ 2 Diabetes mellitus

Biomarkers for the Subclassification of Type 2 Diabetes (Seißler)

The objective of this cooperation group, in which Helmholtz Zentrum München and LMU University Hospital pool their scientific and clinical expertise, is to improve the prediction and prevention of type 2 diabetes for people who have an increased risk but still have a normal glucose metabolism.

Head: Prof. Dr. Jochen Seißler
Tel. +49 89 5160-2200

 

More information about CCG Biomarkers for Subclassification of Typ 2 Diabetes


Allergy

Clinical Allergology Unit

The biology and immunology of surface organs such as the skin are the focus of the patient-oriented research approach of the Clinical Allergology Unit (EKA). Here Helmholtz Zentrum München and the University Hospital rechts der Isar are combining their basic and clinical research expertise in order to develop new methods and to gain insights for an improved prevention, diagnosis and therapy of allergological diseases.

Head: Univ.-Prof. Dr. med. Tilo Biedermann
Tel.: 089/4140 - 3170



Further information


Innovative Therapies

Personalized Radiotherapy in Head and Neck Cancer (Friedl)

In order to personalize the treatment strategy for head and neck tumors, a stratification of the patients with regard to the therapy response is essential. This patient-oriented research approach is pursued jointly in a clinical cooperation group of Helmholtz Zentrum München and LMU University Hospital.

Head: PD Dr. Anna Friedl
Tel. +49 89 2180-75807

More information about CCG Personalized Radiotherapy in Head and Neck Cancer

Clinical Pharmacology Unit

The individual response of the immune system to viral infections is investigated in the patient-oriented research approach of the Clinical Pharmacology Unit (EKliP). Through the combination of expertise in basic research and clinical research of the two partners Helmholtz Zentrum München and LMU University Hospital, personalized concepts for the prevention, diagnosis, and therapy of virus infections are being developed and transferred into clinical application.

Head: Prof. Dr. med. Stefan Endres
Tel.: +49 (0)89 4400-5 7300

More information about the Unit Clinical Pharmacology